EU TRANSPARENCY REGISTER · 878052996061-25 · United States
Mapp Biopharmaceutical
Category
Companies & groups
Country
United States
San Diego
Entity form
corporation
Stated objectives
Develop monoclonal antibody drugs for neglected infectious diseases of importance in public health and biodefense.
As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.
Official profile
The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.
Registered
2025-02-06
Last updated
2026-01-12
Other Companies & groups in United States
Other registered organisations in United States
- 121 Strategies & Government Relations Ltd Professional consultancies
- AAALAC International NGO / platform
- AARP NGO / platform
- ACG Analytics LLC Professional consultancies
- ACM EUROPE NGO / platform
- AI Objectives Institute NGO / platform
- ALLATRA Global Research Center Think tanks and research institutions
- APCO Worldwide Professional consultancies
Frequently asked questions
- What is this organisation?
- Mapp Biopharmaceutical is an interest representative listed in the EU Joint Transparency Register under ID 878052996061-25. Entity form: corporation.
- What category is it registered under?
- It is registered under the category "Companies & groups".
- Which country is it based in?
- The organisation is based in United States, San Diego.
- What are its stated goals?
- As declared by the registrant: Develop monoclonal antibody drugs for neglected infectious diseases of importance in public health and biodefense.
- Where can I find its EU Transparency Register entry?
- The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 878052996061-25.
Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-08 · Commission Reuse Decision 2011/833/EU